Wangta Liu Selected Research

LY 303511

8/2019

LY303511 displays antiproliferation potential against oral cancer cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wangta Liu Research Topics

Disease

16	Neoplasms (Cancer) 11/2022 - 12/2012
5	Neoplasm Metastasis (Metastasis) 11/2022 - 09/2016
4	Infections 01/2017 - 02/2011
3	Mouth Neoplasms (Oral Cancer) 01/2021 - 10/2018
3	Lung Neoplasms (Lung Cancer) 09/2019 - 11/2018
3	Necrosis 04/2015 - 06/2003
2	Breast Neoplasms (Breast Cancer) 02/2022 - 09/2016
2	Lymphatic Metastasis 01/2021 - 09/2016
2	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2019 - 01/2018
2	Carcinogenesis 01/2017 - 01/2017
2	Inflammation (Inflammations) 09/2016 - 01/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 02/2022
1	Kidney Diseases (Kidney Disease) 02/2022
1	Renal Insufficiency (Renal Failure) 02/2022
1	Chronic Renal Insufficiency 02/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Triple Negative Breast Neoplasms 02/2022
1	Leukemia 09/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2020
1	Squamous Cell Carcinoma of Head and Neck 10/2018
1	Hepatocellular Carcinoma (Hepatoma) 05/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 04/2015
1	Edema (Dropsy) 01/2014
1	Fibrosis (Cirrhosis) 12/2012
1	Cholangiocarcinoma 12/2012
1	Virus Diseases (Viral Diseases) 07/2011

Drug/Important Bio-Agent (IBA)

5	Pharmaceutical PreparationsIBA 09/2019 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2012
3	CytokinesIBA 02/2022 - 02/2011
2	CeramidesIBA 05/2022 - 03/2019
2	Small Interfering RNA (siRNA)IBA 09/2019 - 02/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2019 - 10/2018
2	Messenger RNA (mRNA)IBA 01/2017 - 01/2017
1	WithanolidesIBA 11/2022
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2022
1	SphingolipidsIBA 05/2022
1	Uremic ToxinsIBA 02/2022
1	MineralsIBA 02/2022
1	phthalic acid (phthalate)IBA 02/2022
1	EndoglinIBA 02/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2022
1	Diethylhexyl Phthalate (DEHP)IBA 02/2022
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2022
1	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2021
1	Acetylcysteine (Siran)FDA LinkGeneric 09/2021
1	ethyl acetateIBA 09/2021
1	AntioxidantsIBA 09/2021
1	benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketoneIBA 09/2021
1	Neutralizing AntibodiesIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2020
1	DipeptidesIBA 01/2020
1	astaxanthine (astaxanthin)IBA 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2019
1	Annexin A5IBA 08/2019
1	7-aminoactinomycin DIBA 08/2019
1	LY 303511IBA 08/2019
1	8-Hydroxy-2'-DeoxyguanosineIBA 08/2019
1	Superoxides (Superoxide)IBA 08/2019
1	Chloroquine (Aralen)FDA LinkGeneric 03/2019
1	Connexin 43 (Connexin43)IBA 01/2019
1	AcidsIBA 01/2019
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 11/2018
1	CamptothecinIBA 11/2018
1	sandensolideIBA 10/2018
1	cembraneIBA 10/2018
1	4-phenoxyphenolIBA 05/2017
1	TubulinIBA 05/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	Complement C3 (C3 Complement)IBA 01/2017
1	Folic Acid AntagonistsIBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	AdipokinesIBA 09/2016
1	Imatinib Mesylate (Gleevec)FDA Link 09/2016
1	Nicotinamide PhosphoribosyltransferaseIBA 09/2016
1	3,4'-dihydroxystilbeneIBA 10/2015
1	dihydroresveratrolIBA 10/2015
1	Biological ProductsIBA 10/2015
1	Free RadicalsIBA 10/2015
1	ResveratrolIBA 10/2015
1	lunularinIBA 10/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2015
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2015
1	Interferon Type IIBA 04/2015
1	Pattern Recognition ReceptorsIBA 04/2015
1	pimagedine (aminoguanidine)IBA 01/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Methylprednisolone FDA LinkGeneric 01/2014
1	CarrageenanIBA 01/2014
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2014
1	Biomarkers (Surrogate Marker)IBA 12/2012
1	MorpholinosIBA 12/2012
1	Matrix Metalloproteinases (MMPs)IBA 07/2011

Therapy/Procedure

7	Therapeutics 11/2022 - 09/2016
3	Drug Therapy (Chemotherapy) 09/2019 - 10/2018
1	Renal Dialysis (Hemodialysis) 02/2022
1	Radiotherapy 01/2021
1	Injections 12/2012